These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29125944)

  • 1. HLA-A*31:01 and carbamazepine-induced DRESS syndrom in a sample of North African population.
    Ksouda K; Affes H; Mahfoudh N; Chtourou L; Kammoun A; Charfi A; Chaabane H; Medhioub M; Sahnoun Z; Turki H; Tahri N; Hammami S; Zeghal K
    Seizure; 2017 Dec; 53():42-46. PubMed ID: 29125944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
    Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
    J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel multiplex polymerase chain reaction assay for detection of both HLA-A*31:01/HLA-B*15:02 alleles, which confer susceptibility to carbamazepine-induced severe cutaneous adverse reactions.
    Nguyen DV; Vidal C; Chi HC; Do NTQ; Fulton R; Li J; Fernando SL
    HLA; 2017 Dec; 90(6):335-342. PubMed ID: 28884973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the HLA-B*53:01 Allele With Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome During Treatment of HIV Infection With Raltegravir.
    Thomas M; Hopkins C; Duffy E; Lee D; Loulergue P; Ripamonti D; Ostrov DA; Phillips E
    Clin Infect Dis; 2017 May; 64(9):1198-1203. PubMed ID: 28369189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of the HLA-A*3101 allele in a familial case of drug reaction with eosinophilia and systemic symptoms, secondary to carbamazepine.
    Anjum N; Polak ME; Ardern-Jones M; Cooper HL
    Clin Exp Dermatol; 2014 Apr; 39(3):307-9. PubMed ID: 24635066
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Kim H; Chadwick L; Alzaidi Y; Picker J; Poduri A; Manzi S
    Pediatrics; 2018 Apr; 141(Suppl 5):S434-S438. PubMed ID: 29610167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of HLA-A*31:01 Screening With the Incidence of Carbamazepine-Induced Cutaneous Adverse Reactions in a Japanese Population.
    Mushiroda T; Takahashi Y; Onuma T; Yamamoto Y; Kamei T; Hoshida T; Takeuchi K; Otsuka K; Okazaki M; Watanabe M; Kanemoto K; Oshima T; Watanabe A; Minami S; Saito K; Tanii H; Shimo Y; Hara M; Saitoh S; Kinoshita T; Kato M; Yamada N; Akamatsu N; Fukuchi T; Ishida S; Yasumoto S; Takahashi A; Ozeki T; Furuta T; Saito Y; Izumida N; Kano Y; Shiohara T; Kubo M;
    JAMA Neurol; 2018 Jul; 75(7):842-849. PubMed ID: 29610831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) induced by carbamazepine: a case report and literature review.
    E L omairi N; Abourazzak S; Chaouki S; Atmani S; Hida M
    Pan Afr Med J; 2014; 18():9. PubMed ID: 25360193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans.
    McCormack M; Alfirevic A; Bourgeois S; Farrell JJ; Kasperavičiūtė D; Carrington M; Sills GJ; Marson T; Jia X; de Bakker PI; Chinthapalli K; Molokhia M; Johnson MR; O'Connor GD; Chaila E; Alhusaini S; Shianna KV; Radtke RA; Heinzen EL; Walley N; Pandolfo M; Pichler W; Park BK; Depondt C; Sisodiya SM; Goldstein DB; Deloukas P; Delanty N; Cavalleri GL; Pirmohamed M
    N Engl J Med; 2011 Mar; 364(12):1134-43. PubMed ID: 21428769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pustular-type drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to carbamazepine with systemic muscle involvement.
    Matsuda H; Saito K; Takayanagi Y; Okazaki T; Kashima K; Ishikawa K; Kai Y; Takeo N; Hatano Y; Okamoto O; Fujiwara S
    J Dermatol; 2013 Feb; 40(2):118-22. PubMed ID: 23216243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland.
    Wang Q; Zhou JQ; Zhou LM; Chen ZY; Fang ZY; Chen SD; Yang LB; Cai XD; Dai QL; Hong H; Wang HX
    Seizure; 2011 Jul; 20(6):446-8. PubMed ID: 21397523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Human herpes virus 6 infection in an inmunocompetent patient with carbamazepine-induced DRESS syndrome].
    Álvarez S; Delama I; Navajas-Galimany L; Eymin G; Ceballos ME; Andino-Navarrete R
    Rev Chilena Infectol; 2016 Jun; 33(3):340-5. PubMed ID: 27598287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms.
    Konvinse KC; Trubiano JA; Pavlos R; James I; Shaffer CM; Bejan CA; Schutte RJ; Ostrov DA; Pilkinton MA; Rosenbach M; Zwerner JP; Williams KB; Bourke J; Martinez P; Rwandamuriye F; Chopra A; Watson M; Redwood AJ; White KD; Mallal SA; Phillips EJ
    J Allergy Clin Immunol; 2019 Jul; 144(1):183-192. PubMed ID: 30776417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a study of 25 patients in Korea.
    Lee JY; Lee SY; Hahm JE; Ha JW; Kim CW; Kim SS
    Int J Dermatol; 2017 Sep; 56(9):944-951. PubMed ID: 28718873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple and rapid detection of HLA-A*31:01 for prediction of carbamazepine-induced hypersensitivity using loop-mediated isothermal amplification method.
    Niihara H; Kohno K; Taketani T; Kaneko S; Ito T; Sugamori T; Takahashi N; Miyaoka T; Okazaki S; Yasuda H; Furuya M; Nagahama M; Morita E
    J Dermatol Sci; 2014 Apr; 74(1):88-92. PubMed ID: 24388047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, Viral and Genetic Characteristics of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in Shanghai, China.
    Wu X; Yang F; Chen S; Xiong H; Zhu Q; Gao X; Xing Q; Luo X
    Acta Derm Venereol; 2018 Apr; 98(4):401-405. PubMed ID: 29242946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of HLA-B*15:13 and HLA-B*15:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population.
    Chang CC; Ng CC; Too CL; Choon SE; Lee CK; Chung WH; Hussein SH; Lim KS; Murad S
    Pharmacogenomics J; 2017 Mar; 17(2):170-173. PubMed ID: 26927288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug reaction with eosinophilia and systemic symptoms due to carbamazepine. Pediatric case].
    Pereira-Ospina RDP; Bejarano-Quintero AM; Suescún-Vargas JM; Pinzón-Salamanca JY
    Arch Argent Pediatr; 2018 Jun; 116(3):e433-e436. PubMed ID: 29756718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulthiame-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
    Fong CY; Hashim N; Gan CS; Chow TK; Tay CG
    Eur J Paediatr Neurol; 2016 Nov; 20(6):957-961. PubMed ID: 27524391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of DRESS syndrome.
    López-Rocha E; Blancas L; Rodríguez-Mireles K; Gaspar-López A; O'Farrill-Romanillos P; Amaya-Mejía A; Galindo-Pacheco L; Campos-Romero F; Aguilar-Hinojosa N; Suárez G
    Rev Alerg Mex; 2014; 61(1):14-23. PubMed ID: 24912998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.